Skip to main content

Table 1 Synovial fluid pharmacokinetic parameters

From: Synovial fluid pharmacokinetics of tulathromycin, gamithromycin and florfenicol after a single subcutaneous dose in cattle

  

Florfenicol

Gamithromycin

Tulathromycin

  

Mean

SD

Mean

SD

Mean

SD

C max

mcg/mL

2.71

0.93

0.14

0.11

0.79

0.57

T max

hr

7

2

8

0

19

10

λz

/hr

0.0115

0.0035

0.0099

0.0038

0.0077

0.0038

t ½λz

hr

64.9

20.1

77.9

30.0

109.0

53.9

AUC last

mcg*hr/mL

142.0

17.5

6.2

2.8

49.7

29.1

AUC 0-inf

mcg*hr/mL

154.0

26.2

6.5

2.9

57.6

28.2

AUC % Extrap

 

7.1

6.3

6.2

2.8

18.1

12.1

AUMC 0-obs

mcg*hr2/mL

7623

2577

331

122

3323

1577

AUMC 0-inf

mcg*hr2/mL

11860

7054

469

124

6490

1311

MRT 0-obs

hr

53.5

15.4

55.9

14.2

71.7

14.4

MRT 0-inf

hr

74.1

32.9

75.2

12.3

136.5

65.0

  1. Tmax: time of peak serum drug concentration; Cmax: peak drug concentration; t1/2: apparent elimination half-life calculated as ln(2)/λz, λz being the first order rate constant associated with the terminal portion of the time-concentration curve; AUC0-obs: area under the time-concentration curve from time zero to the last observed concentration; AUC0-inf: area under the time-concentration curve from time zero extrapolated to infinity; AUMC0-obs: area under the moment curve from time zero to the last observed concentration; AUMC0-inf: area under the moment curve from time zero extrapolated to infinity; MRT0-obs: Mean Resident Time calculated as AUMC0-obs /AUC0-obs; MRT0-inf: Mean Residence Time calculated as AUMC0-inf /AUC0-inf.
  2. Mean pharmacokinetic parameters in synovial fluid estimated via noncompartmental analysis after SC administration of florfenicol (40 mg/kg), gamithromycin (6 mg/kg), and tulathromycin (2.5 mg/kg) (n = 4/group).